- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 295/027 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
Patent holdings for IPC class C07D 295/027
Total number of patents in this class: 71
10-year publication summary
|
7
|
4
|
6
|
10
|
9
|
3
|
1
|
3
|
4
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 20945 |
4 |
| Uop LLC | 4240 |
4 |
| Zydus Lifesciences Limited | 115 |
3 |
| Blade Therapeutics, Inc. | 19 |
2 |
| Korea Research Institute of Chemical Technology | 1394 |
2 |
| Lundbeck Pharmaceuticals Italy S.p.A. | 25 |
2 |
| Wuhan LL Science and Technology Development Co., Ltd | 71 |
2 |
| Xi'an Crysten Materials Technology Corporation Limited | 4 |
2 |
| Viatris Specialty LLC | 158 |
2 |
| General Electric Company | 13806 |
1 |
| Evonik Degussa GmbH | 1520 |
1 |
| Dow Global Technologies LLC | 10371 |
1 |
| Aerie Pharmaceuticals, Inc. | 42 |
1 |
| Alcon, Inc. | 5449 |
1 |
| Apogee Biotechnology Corporation | 14 |
1 |
| Baylor University | 340 |
1 |
| Calyx Chemicals and Pharmaceuticals Pvt. Ltd. | 1 |
1 |
| Cellix Bio Private Limited | 52 |
1 |
| Celltrion Chemical Research Institute | 6 |
1 |
| Celltrion Pharm, Inc. | 8 |
1 |
| Other owners | 37 |